128 related articles for article (PubMed ID: 8280162)
21. Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B.
Swanson SK; Born T; Zydowsky LD; Cho H; Chang HY; Walsh CT; Rusnak F
Proc Natl Acad Sci U S A; 1992 May; 89(9):3741-5. PubMed ID: 1315036
[TBL] [Abstract][Full Text] [Related]
22. Interaction of cyclosporin A and two cyclosporin analogs with cyclophilin: relationship between structure and binding.
Zeder-Lutz G; Van Regenmortel MH; Wenger R; Altschuh D
J Chromatogr B Biomed Appl; 1994 Dec; 662(2):301-6. PubMed ID: 7719484
[TBL] [Abstract][Full Text] [Related]
23. NMR studies of [U-13C]cyclosporin A bound to cyclophilin: bound conformation and portions of cyclosporin involved in binding.
Fesik SW; Gampe RT; Eaton HL; Gemmecker G; Olejniczak ET; Neri P; Holzman TF; Egan DA; Edalji R; Simmer R
Biochemistry; 1991 Jul; 30(26):6574-83. PubMed ID: 2054356
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporin G and metabolite binding to cyclophilin and a 50-kDa binding protein related to in vitro immunosuppression.
Donnelly JG; Chen Y; Yatscoff RW; Copeland KR; Palaszynski EW; Soldin SJ
Clin Chem; 1993 Jan; 39(1):122-5. PubMed ID: 8419033
[TBL] [Abstract][Full Text] [Related]
25. Expression of human cyclophilin-40 and the effect of the His141-->Trp mutation on catalysis and cyclosporin A binding.
Hoffmann K; Kakalis LT; Anderson KS; Armitage IM; Handschumacher RE
Eur J Biochem; 1995 Apr; 229(1):188-93. PubMed ID: 7744028
[TBL] [Abstract][Full Text] [Related]
26. Cyclophilin B trafficking through the secretory pathway is altered by binding of cyclosporin A.
Price ER; Jin M; Lim D; Pati S; Walsh CT; McKeon FD
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3931-5. PubMed ID: 7909608
[TBL] [Abstract][Full Text] [Related]
27. Mechanistic implication of crystal structures of the cyclophilin-dipeptide complexes.
Zhao Y; Ke H
Biochemistry; 1996 Jun; 35(23):7362-8. PubMed ID: 8652512
[TBL] [Abstract][Full Text] [Related]
28. The NMR structure of cyclosporin A bound to cyclophilin in aqueous solution.
Weber C; Wider G; von Freyberg B; Traber R; Braun W; Widmer H; Wüthrich K
Biochemistry; 1991 Jul; 30(26):6563-74. PubMed ID: 2054355
[TBL] [Abstract][Full Text] [Related]
29. Conformational polymorphism in peptidic and nonpeptidic drug molecules.
Taylor P; Mikol V; Kallen J; Burkhard P; Walkinshaw MD
Biopolymers; 1996; 40(5):585-92. PubMed ID: 9101762
[TBL] [Abstract][Full Text] [Related]
30. Specific interaction between cyclophilin and cyclic peptides.
Gallo P; Saviano M; Rossi F; Pavone V; Pedone C; Ragone R; Stiuso P; Colonna G
Biopolymers; 1995 Sep; 36(3):273-81. PubMed ID: 7669915
[TBL] [Abstract][Full Text] [Related]
31. Structure-based design of a cyclophilin-calcineurin bridging ligand.
Alberg DG; Schreiber SL
Science; 1993 Oct; 262(5131):248-50. PubMed ID: 8211144
[TBL] [Abstract][Full Text] [Related]
32. Two new cyclophilins from Fusarium sambucinum and Aspergillus niger: resistance of cyclophilin/cyclosporin A complexes against proteolysis.
Hornbogen T; Pieper R; Hoffmann K; Kleinkauf H; Zocher R
Biochem Biophys Res Commun; 1992 Sep; 187(2):791-6. PubMed ID: 1530635
[TBL] [Abstract][Full Text] [Related]
33. Cyclosporin A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T cell signal transduction.
Walsh CT; Zydowsky LD; McKeon FD
J Biol Chem; 1992 Jul; 267(19):13115-8. PubMed ID: 1618811
[TBL] [Abstract][Full Text] [Related]
34. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
Bierer BE
Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
[No Abstract] [Full Text] [Related]
35. Improved binding affinity for cyclophilin A by a cyclosporin derivative singly modified at its effector domain.
Papageorgiou C; Florineth A; Mikol V
J Med Chem; 1994 Oct; 37(22):3674-6. PubMed ID: 7966126
[No Abstract] [Full Text] [Related]
36. Determination of the NMR solution structure of the cyclophilin A-cyclosporin A complex.
Spitzfaden C; Braun W; Wider G; Widmer H; Wüthrich K
J Biomol NMR; 1994 Jul; 4(4):463-82. PubMed ID: 8075536
[TBL] [Abstract][Full Text] [Related]
37. Controlling programmed cell death with a cyclophilin-cyclosporin-based chemical inducer of dimerization.
Belshaw PJ; Spencer DM; Crabtree GR; Schreiber SL
Chem Biol; 1996 Sep; 3(9):731-8. PubMed ID: 8939689
[TBL] [Abstract][Full Text] [Related]
38. Crystallisation and preliminary X-ray diffraction studies of cyclophilin-tetrapeptide and cyclophilin-cyclosporin complexes.
Zurini M; Kallen J; Mikol V; Pfluegl G; Jansonius JN; Walkinshaw MD
FEBS Lett; 1990 Dec; 276(1-2):63-6. PubMed ID: 2265714
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporin A-cyclophilin complex formation. A model based on X-ray and NMR data.
Spitzfaden C; Weber HP; Braun W; Kallen J; Wider G; Widmer H; Walkinshaw MD; Wüthrich K
FEBS Lett; 1992 Apr; 300(3):291-300. PubMed ID: 1555658
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of murine cyclophilin C complexed with immunosuppressive drug cyclosporin A.
Ke H; Zhao Y; Luo F; Weissman I; Friedman J
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11850-4. PubMed ID: 8265636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
